CBPB

DRUG2 trials

Sponsors

Tanabe Pharma Corporation

Conditions

Chronic Kidney DiseaseDialysisHyperphosphatemiaPaediatric

Phase 3

Long-term Extension Study of MCI-196

TerminatedNCT01814917

Tanabe Pharma CorporationChronic Kidney Disease, Dialysis, Hyperphosphatemia +1

Start: 2013-08-31End: 2014-12-31Updated: 2015-05-27

Dose-finding Study of MCI-196

TerminatedNCT01814904

Tanabe Pharma CorporationChronic Kidney Disease, Dialysis, Hyperphosphatemia +1

Start: 2014-04-30End: 2015-01-31Updated: 2015-05-27